Healius Limited (ASX:HLS)
0.4450
0.00 (0.00%)
Sep 17, 2026, 4:10 PM AEST
Healius Market Cap
Healius has a market cap or net worth of 323.14 million as of September 16, 2026. Its market cap has decreased by -42.58% in one year.
Market Cap
323.14M
Enterprise Value
1.25B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
ChartMarket Cap Chart
Since August 29, 2000, Healius's market cap has decreased from 478.57M to 323.14M, a decrease of -32.48%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 323.14M | -50.83% |
| Dec 31, 2025 | 657.15M | -33.94% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.66B |
| Integral Diagnostics | 871.62M |
| Australian Clinical Labs | 525.53M |
| Monash IVF Group | 300.02M |
| Cryosite | 57.60M |
| Microba Life Sciences | 37.12M |
| Rhythm Biosciences | 28.31M |
| BCAL Diagnostics | 25.81M |